#USA #Leesburg #Haier Biomedical #Resonant Solutions #Benchtop Centrifuge

Introduction

Resonant Clinical Solutions, a prominent global partner in clinical solutions, has joined forces with Haier Biomedical to launch a state-of-the-art benchtop centrifuge that employs a natural refrigerant. This innovative device comes at a pivotal time as the life sciences sector faces stringent F-gas regulatory changes in Europe and North America.

The New Centrifuge: LX-60T100R

The newly introduced hydrocarbon-cooled LX-60T100R centrifuge is specifically intended for clinical trial applications. It not only meets but exceeds the existing needs of pharmaceutical sponsors and contract research organizations (CROs), offering a reduction in environmental impact while ensuring high performance.

Features and Benefits

1. Natural Hydrocarbon Refrigerant: Unlike traditional systems that relied on F-gases with high global warming potential (GWP), this centrifuge uses a natural hydrocarbon refrigerant (R290), drastically cutting down its environmental footprint.
2. Rapid Pre-Cooling: The centrifuge can cool from room temperature to 4 °C in just about five minutes, thereby significantly reducing wait times commonly faced when utilizing older refrigerated centrifuges.
3. Speed and Rotor Customization: Engineered specifically for routine clinical workflows, this centrifuge accommodates a variety of sample sizes, including blood collection tubes and conical flasks.
4. User-Friendly Interface: An advanced 7-inch LCD touchscreen allows users to navigate easily, even when wearing gloves. The interface supports on-screen calibration, configuration, and user log-in, catering to modern laboratory environments.
5. Safety and Reliability: The centrifuge is equipped with built-in monitoring for safety and reliability, detecting issues such as imbalance and vibration, ensuring optimal operational conditions.
6. Quiet Operation: Its silent operation at 52 dB(A) is designed to be lab-friendly, making it suitable for shared environments and lengthy processing tasks.
7. Compact Design: Weighing around 46 kg, the centrifuge can be placed on standard laboratory benches without requiring special installations, making it accessible for various laboratory setups.
8. Significantly Lowered GWP: The transformation from F-gas systems' GWP of over 1,400 down to approximately 3 reflects a drastic improvement in environmental sustainability without compromising cooling efficacy.

Collaborating for Innovation

Christophe Berthoux, CEO of Resonant Clinical Solutions, emphasized the significance of this partnership with Haier Biomedical. He stated, "This collaboration is pivotal in delivering innovative technology that adheres to F-gas regulations while meeting market demands, well ahead of designated industry deadlines. The new centrifuge enhances clinical trial workflows, making them more flexible and environmentally sustainable."

Haier Biomedical's Co-CEO, Gang Liu, echoed this sentiment, highlighting the organization's commitment to responding proactively to emerging challenges within the biomedical sphere. He noted that the partnership has resulted in a user-centric centrifuge that significantly improves laboratory workflows while minimizing harmful greenhouse gas usage.

Availability and Purchase Options

Clinical trial sponsors and CROs can purchase or rent the LX-60T100R centrifuge directly from Resonant until November 2027. Currently available in the 220–240 V AC format, a 110 V AC version will launch in Q1 2027, catering to diverse laboratory requirements.

Conclusion

The collaborative effort between Resonant Clinical Solutions and Haier Biomedical underscores a significant leap in technology, addressing both regulatory compliance and environmental concerns in one innovative product. The LX-60T100R sets a new standard in clinical trial equipment, offering enhanced efficiency and sustainability, thereby supporting the advancement of health science research globally.

For more information on the LX-60T100R centrifuge, please visit Resonant Clinical Solutions.